Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020).
- DOI
- 10.1016/j.molmed.2021.01.004
- Published
- 2021 Apr
- Container
- Trends in molecular medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.molmed.2021.01.004,
title = {Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020).},
author = {Bar-Or A and Pender MP and Khanna R and Steinman L and Hartung HP and Maniar T and Croze E and Aftab BT and Giovannoni G and Joshi MA},
year = {2021},
journal = {Trends in molecular medicine},
doi = {10.1016/j.molmed.2021.01.004},
url = {https://doi.org/10.1016/j.molmed.2021.01.004}
}RIS
TY - JOUR TI - Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020). AU - Bar-Or A AU - Pender MP AU - Khanna R AU - Steinman L AU - Hartung HP AU - Maniar T AU - Croze E AU - Aftab BT AU - Giovannoni G AU - Joshi MA PY - 2021 JO - Trends in molecular medicine DO - 10.1016/j.molmed.2021.01.004 UR - https://doi.org/10.1016/j.molmed.2021.01.004 ER -
APA
A, B., MP, P., R, K., L, S., HP, H., T, M., E, C., BT, A., G, G., & MA, J. (2021). Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020).. Trends in molecular medicine. https://doi.org/10.1016/j.molmed.2021.01.004
Source records
- pubmed · retrieved 2026-09-26T19:45:24.591Z